View in EDS HTML Full Text PDF Full Text

Risk of hepatocellular carcinoma in treatment-naïve chronic hepatitis B patients receiving tenofovir disoproxil fumarate versus entecavir in the United States.

Saved in:
Bibliographic Details
Title: Risk of hepatocellular carcinoma in treatment-naïve chronic hepatitis B patients receiving tenofovir disoproxil fumarate versus entecavir in the United States.
Authors: Kim WR; Stanford University School of Medicine, Stanford, CA, USA., Telep LE; Gilead Sciences Inc., Foster City, CA, USA., Jump B; Gilead Sciences Inc., Foster City, CA, USA., Lu M; Henry Ford Health System, Detroit, MI, USA., Ramroth H; Gilead Sciences Inc., Foster City, CA, USA., Flaherty J; Gilead Sciences Inc., Foster City, CA, USA., Gaggar A; Gilead Sciences Inc., Foster City, CA, USA., Chokkalingam AP; Gilead Sciences Inc., Foster City, CA, USA., Gordon SC; Henry Ford Health System, Detroit, MI, USA.
Source: Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2022 Apr; Vol. 55 (7), pp. 828-835. Date of Electronic Publication: 2022 Feb 08.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 8707234 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2036 (Electronic) Linking ISSN: 02692813 NLM ISO Abbreviation: Aliment Pharmacol Ther Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 35137422
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Risk of hepatocellular carcinoma in treatment-naïve chronic hepatitis B patients receiving tenofovir disoproxil fumarate versus entecavir in the United States.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Kim+WR%22">Kim WR</searchLink>; Stanford University School of Medicine, Stanford, CA, USA.<br /><searchLink fieldCode="AU" term="%22Telep+LE%22">Telep LE</searchLink>; Gilead Sciences Inc., Foster City, CA, USA.<br /><searchLink fieldCode="AU" term="%22Jump+B%22">Jump B</searchLink>; Gilead Sciences Inc., Foster City, CA, USA.<br /><searchLink fieldCode="AU" term="%22Lu+M%22">Lu M</searchLink>; Henry Ford Health System, Detroit, MI, USA.<br /><searchLink fieldCode="AU" term="%22Ramroth+H%22">Ramroth H</searchLink>; Gilead Sciences Inc., Foster City, CA, USA.<br /><searchLink fieldCode="AU" term="%22Flaherty+J%22">Flaherty J</searchLink>; Gilead Sciences Inc., Foster City, CA, USA.<br /><searchLink fieldCode="AU" term="%22Gaggar+A%22">Gaggar A</searchLink>; Gilead Sciences Inc., Foster City, CA, USA.<br /><searchLink fieldCode="AU" term="%22Chokkalingam+AP%22">Chokkalingam AP</searchLink>; Gilead Sciences Inc., Foster City, CA, USA.<br /><searchLink fieldCode="AU" term="%22Gordon+SC%22">Gordon SC</searchLink>; Henry Ford Health System, Detroit, MI, USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%228707234%22">Alimentary pharmacology & therapeutics</searchLink> [Aliment Pharmacol Ther] 2022 Apr; Vol. 55 (7), pp. 828-835. <i>Date of Electronic Publication: </i>2022 Feb 08.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Wiley-Blackwell%22">Wiley-Blackwell </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>8707234 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1365-2036 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2202692813%22">02692813 </searchLink><i>NLM ISO Abbreviation: </i>Aliment Pharmacol Ther <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=35137422
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1111/apt.16786
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 828
    Titles:
      – TitleFull: Risk of hepatocellular carcinoma in treatment-naïve chronic hepatitis B patients receiving tenofovir disoproxil fumarate versus entecavir in the United States.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Kim WR
      – PersonEntity:
          Name:
            NameFull: Telep LE
      – PersonEntity:
          Name:
            NameFull: Jump B
      – PersonEntity:
          Name:
            NameFull: Lu M
      – PersonEntity:
          Name:
            NameFull: Ramroth H
      – PersonEntity:
          Name:
            NameFull: Flaherty J
      – PersonEntity:
          Name:
            NameFull: Gaggar A
      – PersonEntity:
          Name:
            NameFull: Chokkalingam AP
      – PersonEntity:
          Name:
            NameFull: Gordon SC
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 04
              Text: 2022 Apr
              Type: published
              Y: 2022
          Identifiers:
            – Type: issn-electronic
              Value: 1365-2036
          Numbering:
            – Type: volume
              Value: 55
            – Type: issue
              Value: 7
          Titles:
            – TitleFull: Alimentary pharmacology & therapeutics
              Type: main
ResultId 1